CSPC Pharmaceutical Group Limited (CVG) — Capital Reinvestment Ratio
CSPC Pharmaceutical Group Limited (CVG) has a Capital Reinvestment Ratio of 0.12x as of September 2020, meaning it reinvests 0% of its operating cash flow (€2.16 Billion) in capital expenditures (€258.14 Million). See CSPC Pharmaceutical Group Limited (CVG) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CSPC Pharmaceutical Group Limited Capital Reinvestment Ratio (2013–2025)
This chart tracks CSPC Pharmaceutical Group Limited's Capital Reinvestment Ratio across 13 annual periods. Check CSPC Pharmaceutical Group Limited (CVG) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for CSPC Pharmaceutical Group Limited (2013–2025)
Year-by-year Capital Reinvestment Ratio for CSPC Pharmaceutical Group Limited from 2013 to 2025. For live market cap and broader valuation context, see CVG company net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | €5.83 Billion | €2.28 Billion | ▼ -33.8% |
| 2024 | 0.59x | €4.53 Billion | €2.68 Billion | ▲ +30.4% |
| 2023 | 0.45x | €4.18 Billion | €1.89 Billion | ▲ +55.6% |
| 2022 | 0.29x | €7.63 Billion | €2.22 Billion | ▼ -4.3% |
| 2021 | 0.30x | €4.64 Billion | €1.41 Billion | ▲ +51.1% |
| 2020 | 0.20x | €6.74 Billion | €1.36 Billion | ▼ -59.6% |
| 2019 | 0.50x | €3.78 Billion | €1.88 Billion | ▲ +13.3% |
| 2018 | 0.44x | €3.80 Billion | €1.67 Billion | ▲ +22.6% |
| 2017 | 0.36x | €3.29 Billion | €1.18 Billion | ▼ -1.7% |
| 2016 | 0.36x | €2.92 Billion | €1.06 Billion | ▲ +0.4% |
| 2015 | 0.36x | €2.25 Billion | €815.69 Million | ▼ -18.8% |
| 2014 | 0.45x | €1.81 Billion | €807.00 Million | ▼ -39.0% |
| 2013 | 0.73x | €814.86 Million | €597.12 Million | — |